Transmedics Group Inc
(TMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | |
| Sales | 2,519 |
| Cost of Goods | 1,595 |
| Gross Profit | 924 |
| Operating Expenses | 6,300 |
| Operating Income | -4,781 |
| Interest Expense | 258 |
| Other Income | 145 |
| Pre-tax Income | -4,894 |
| Income Tax | 7 |
| Net Income Continuous | -4,901 |
| Net Income | $-4,901 |
| EPS Basic Total Ops | -3.61 |
| EPS Basic Continuous Ops | -3.61 |
| EPS Diluted Total Ops | -3.61 |
| EPS Diluted Continuous Ops | -3.61 |
| EBITDA(a) | $-4,615 |